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Abstract
Background: Verbal autopsies provide valuable information for studying mortality patterns in populations that lack
reliable vital registration data. Methods for transforming verbal autopsy results into meaningful information for
health workers and policymakers, however, are often costly or complicated to use. We present a simple additive
algorithm, the Tariff Method (termed Tariff), which can be used for assigning individual cause of death and for
determining cause-specific mortality fractions (CSMFs) from verbal autopsy data.
Methods: Tariff calculates a score, or “tariff,” for each cause, for each sign/symptom, across a pool of validated
verbal autopsy data. The tariffs are summed for a given response pattern in a verbal autopsy, and this sum (score)
provides the basis for predicting the cause of death in a dataset. We implemented this algorithm and evaluated
the method’s predictive ability, both in terms of chance-corrected concordance at the individual cause assignment
level and in terms of CSMF accuracy at the population level. The analysis was conducted separately for adult, child,
and neonatal verbal autopsies across 500 pairs of train-test validation verbal autopsy data.
Results: Tariff is capable of outperforming physician-certified verbal autopsy in most cases. In terms of chance-
corrected concordance, the method achieves 44.5% in adults, 39% in children, and 23.9% in neonates. CSMF
accuracy was 0.745 in adults, 0.709 in children, and 0.679 in neonates.
Conclusions: Verbal autopsies can be an efficient means of obtaining cause of death data, and Tariff provides an
intuitive, reliable method for generating individual cause assignment and CSMFs. The method is transparent and
flexible and can be readily implemented by users without training in statistics or computer science.
Keywords: Verbal autopsy, validation, gold standard, Tariff Method, cause of death, mortality, cause-specific mortal-
ity fractions
Background
Verbal autopsies (VAs) are increasingly being used to
provide information on causes of death in demographic
surveillance sites (DSSs), national surveys, censuses, and
sample registration schemes [1-3]. Physician-certified
verbal autopsy (PCVA) is the primary method used to
assign cause once VA data are collected. Several alterna-
tive expert-based algorithms [4-6], statistical methods
[7-9], and computational algorithms [7] have been
developed. These methods hold promise, but their
comparative performance needs to be evaluated. Large-
scale validation studies, such as the Population Health
Metrics Research Consortium (PHMRC) [10], provide
objective information on the performance of these dif-
ferent approaches.
The main limitation to date of PCVA is the cost and
feasibility of implementation. Finding and training physi-
cians to read VAs in resource-poor settings has proven
challenging, leading in some cases to long delays in the
analysis of data [1,11]. In some rural areas with marked
shortages of physicians, assigning the few available phy-
s i c i a n st or e a dV A sm a yh a v eav e r yh i g ho p p o r t u n i t y
cost in terms of health care delivery. Lozano et al. [12]
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any medium, provided the original work is properly cited.have also shown that there is a substantial idiosyncratic
element to PCVA related to physician diagnostic perfor-
mance. In contrast, some automated methods (whether
statistical or computational in nature) have demon-
strated performance similar to PCVA [7,8], but some
users may be uncomfortable with the “black box” nature
of these techniques. It is often very difficult for users to
unpack how decisions on a cause are reached. Further-
more, the actual statistics and mechanics that form the
basis for cause assignments are difficult to access and
understand due to the myriad computations involved.
One method, the King-Lu method, is a direct cause-spe-
cific mortality fraction (CSMF) estimation approach
[13,14] that does not assign cause to specific deaths,
making it even harder for a user to understand how the
cause of death is being determined.
Empirical methods that use the observed response
pattern from VAs in a training dataset have an advan-
tage over expert judgment-based methods in that they
c a p t u r et h er e a l i t yt h a ts o m eh o u s e h o l dr e s p o n d e n t si n
a VA interview may respond “yes” to some items even
when they would not be considered part of the classical
clinical presentation for that cause. For example, 43% of
households report coughing as a symptom for patients
who died from a fall, and 58% of households report a
fever for patients who died from a road traffic accident.
However, a limitation of many existing methods such as
Simplified Symptom Pattern and Random Forest is that
they may not give sufficient emphasis to pathognomonic
signs and symptoms. For example, if 20% of patients
dying of epilepsy report convulsions, and only 2% of
nonepilepsy patients report convulsions, a statistical
model will not assign this symptom as much signifi-
cance as these data imply. Put another way, Bayesian
methods such as InterVA and Symptom Pattern and
statistical methods such as King-Lu direct CSMF esti-
mation assume that the probability of signs and symp-
toms conditional on true cause is constant, but in reality
it is not. There are subsets of patients who may have
signs and symptoms that are extremely informative, and
other subsets with less clearly defined signs/symptoms.
In this paper, we propose a simple additive approach
using transparent, intuitive computations based on
responses to a VA instrument. Our premise is that there
ought to be highly informative signs or symptoms for
each cause. Our goal is to develop an approach to cause
of death estimation based on reported signs and symp-
toms that is simple enough to be implemented in a
spreadsheet so that users can follow each step of cause
assignment. We illustrate the development of this
approach and then use the PHMRC gold standard VA
validation study dataset [10] to assess the performance
of this approach compared to PCVA, which is current
practice.
Methods
Logic of the method
The premise behind the Tariff Method is to identify
signs or symptoms collected in a VA instrument that
are highly indicative of a particular cause of death. The
general approach is as follows. A tariff is developed for
each sign and symptom for each cause of death to
r e f l e c th o wi n f o r m a t i v et h a ts i g na n ds y m p t o mi sf o r
that cause. For a given death, based on the response
pattern in the VA instrument, the tariffs are then
summed yielding an item-specific tariff score for each
death for each cause. The cause that claims the highest
tariff score for a particular death is assigned as the pre-
dicted cause of death for that individual. The tariffs, tar-
iff scores, and ranks are easily observable at each step,
and users can readily inspect the basis for any cause
decision.
Based on a training dataset in which the true cause is
known and a full verbal autopsy has been collected, we
can compute a tariff as a function of the fraction of
deaths for each variable or item that has a positive
response. The tariff can be thought of as a robust esti-
mate of how different an item response pattern is for a
cause compared to other causes, formally:
Tarif fij =
xij − Median

xij

Interquartile Range xij
where tariffij is the tariff for cause i, item j, xij is the
fraction of VAs for which there is a positive response to
deaths from cause i for item j, median(xij)i st h em e d i a n
fraction with a positive response for item j across all
causes, and interquartile range xij is the interquartile
range of positive response rates averaged across causes.
Note that as defined, tariffs can be positive or negative
in value. As a final step, tariffs are rounded to the near-
est 0.5 to avoid overfitting and to improve predictive
validity.
For each death, we compute summed tariff scores for
each cause:
Tariff Scoreki =
w 
j=1
Tarif fij xjk
where xjk is the response for death k on item j, taking
on a value of 1 when the response is positive and 0
when the response is negative, and w is the number of
items used for the cause prediction. It is key to note
that for each death, a different tariff score is computed
for each of the possible causes. In the adult module of
the PHMRC study, for example, there are 46 potential
causes and so there are 46 different tariff scores based
on the tariffs and the response pattern for that death.
For actual implementation, we use only the top 40 items
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score. The set of 40 items used for each cause predic-
tion are not mutually exclusive, though cumulatively
across all cause predictions the majority of items in the
PHMRC VA questionnaire are used for at least one
cause prediction.
Once a set of tariff scores has been obtained for a
given death, the cause of death can be assigned in sev-
eral ways. The easiest method is to simply assign the
cause with the highest tariff score. However, some
causes may have inherently higher tariffs. To address
this issue, each test death’s cause-specific score is
ranked in comparison to all of that cause’ss c o r e sf o r
deaths in the training dataset, which has been resampled
to have a uniform cause distribution. This ranking
transformation normalizes the tariff scores and draws
on the information found in the training dataset. The
cause that claims the highest rank on each death being
tested receives the cause assignment for that death. In
repeated tests, we have found the ranking transforma-
tion improves performance and is the preferred final
step for assigning cause. By making cause assignments
based on rank for each individual death through the use
of the training dataset, we also emulate how the method
could be used for individual cause assignment in the
field, since cause assignment in the field would be based
on ranking a single death relative to the entire validation
dataset’s tariff scores. This entire process is illustrated in
Figure 1.
Implementation of the Tariff Method
We use the PHMRC gold standard VA training datasets
to develop tariffs and then to assess the performance of
Tariff compared to PCVA. Details on the design of this
multicountry study are provided elsewhere [10]. The
study collected 7,836 adult, 2,075 child, and 2,631 neo-
natal deaths with rigorously defined clinical diagnostic
and pathological criteria. For each death, the PHMRC
VA instrument was applied. The resulting VA dataset
consists of responses to symptoms and signs that may
be expressed as dichotomous, continuous, and categori-
cal variables. The survey instrument also included items
for the interviewer to transcribe medical record text
from the household and to take notes during the “open
response” portion of the interview, when the respondent
explains anything else that he/she feels is relevant. The
text from these responses has been converted to dichot-
omous items. The continuous and categorical variables,
such as “how long did the fever last?” were also con-
verted to dichotomous variables. These data processing
steps are described in more detail elsewhere [10]. We
use the dichotomized training datasets to develop tariffs.
We then compute tariff scores for each death in the test
and train datasets and assign a cause of death to each
death in the test dataset. We compute chance-corrected
concordance and CSMF accuracy [15] on the cause of
death predictions in the test dataset to avoid in-sample
analysis. Chance-corrected concordance is a sensitivity
assessment that measures the method’s ability to cor-
rectly determine individual cause of death. CSMF accu-
racy is an index that measures a VA method’s ability to
estimate a population’s cause-specific mortality fractions
and is determined by calculating the sum of the absolute
value of CSMF errors compared to the maximum possi-
ble error in CSMFs. Examination of the tariff score
ranks can yield a second, third, etc., most likely cause of
death. We also compute partial chance-corrected con-
cordance for up to six causes [15]. We undertake sepa-
rate analyses for adult, child, and neonatal deaths. It is
important to note that for each train-test data split from
the PHMRC study, we compute a new set of tariffs
b a s e do n l yo nt h a tp a r t i c u l a rt r a i n i n gs e t .I no t h e r
words, in no case are test data used in the development
of the tariff that is applied to that particular test dataset.
We have repeated the development of tariffs and tariff
scores using household recall of health care experience
(HCE) and excluding these variables [10] in order to
estimate the method’s performance in settings where
access to health care is uncommon. HCE items capture
any information that the respondent may know about
the decedent’s experiences with health care. For exam-
ple, the items “Did [name] have AIDS?” or “Did [name]
have cancer?” would be considered HCE items. Text
collected from the medical record is also classified as
HCE information. For example, the word “malaria”
might be written on the decedent’s health records and
would be considered an HCE item. Based on the valida-
tion dataset collected by the PHMRC [10], we were able
to estimate causes of death and evaluate the method for
34 causes for adults, 21 causes for children, and 11
causes for neonates. We compared Tariff’s performance
to PCVA for the same cause lists and item sets for the
adult and child results; however, PCVA produces esti-
mates for only six neonate causes and consequently
direct comparison for neonates was not possible.
In order to analyze the performance of Tariff in com-
parison with PCVA across a variety of cause of death
distributions, 500 different cause compositions based on
uninformative Dirichlet sampling [10] were processed
with both Tariff and PCVA. The frequency with which
Tariff outperforms PCVA in both chance-corrected con-
cordance and CSMF accuracy is then computed across
these 500 population cause-specific constructs.
Results
Tariffs
Table 1 shows selected tariffs that exemplify pathologi-
cal plausibility and how certain signs/symptoms are
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other causes. For example, in predicting diabetes with
skin infection, the sign of an “ulcer oozing pus” has a
positive response rate frequency that is 25 interquartile
ranges above the median frequency for this sign across
causes. This will result in any death reporting this sign
to be highly-ranked within the cause prediction scores.
The word “cancer” b e i n gw r i t t e no no n e ’sh e a l t hc a r e
records has a relatively high tariff for both esophageal
cancer and cervical cancer, demonstrating that it has
predictive value despite being less specific than other
items. It is interesting to note that approximately 50% of
Full Dataset 
for Adult 
Module
Random sampling 
without 
replacement by 
cause
Tariff computed for each 
cause, for each sign/symptom
Resampled with replacement 
based on uninformative Dirichlet 
draw
25% test 
dataset
75% train 
dataset
Resampled 
test dataset
For each death in train 
dataset, scores for each cause 
are calculated by summing 
tariffs for endorsed items
For each death in resampled test 
dataset, scores for each cause are 
calculated by summing tariffs 
(from train dataset tariff matrix) 
for endorsed items
Tariff 
matrix
Each cause score for each death is 
ranked relative to the 
corresponding cause score 
distribution in the train data
Cause assignment 
decided by cause with 
highest rank 
on each death
Cause-specific mortality fraction 
accuracy and chance-corrected 
concordance computed for all 
deaths in resampled test dataset
Training dataset is resampled 
with replacement to have a 
uniform cause distribution
Repeated 500 times
Figure 1 Schematic diagram showing the process of making cause assignments starting with the full dataset. All steps within the boxed
area are repeated 500 times.
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sions, and 50% of diabetes with skin infection deaths
reported ulcer oozing pus, yet these two sign-cause
combinations have markedly different tariffs. This
reflects how the tariff computation can capture both the
strength and uniqueness of a sign/symptom in predict-
ing a cause. These two examples have equal strength in
terms of the sign/symptom-cause endorsement rate, but
the sign “ulcer oozing pus” is more unique to diabetes
with skin infection than convulsions are to hypertensive
disorders.
Additional files 1, 2, and 3 show the tariffs (derived
from the full dataset) for the top 40 items based on tar-
iff absolute value for each cause for the adult, child, and
neonate modules, respectively.
Validation of Tariff cause assignment
Individual death assignment
Table 2 compares overall median chance-corrected con-
cordance across 500 train-test data splits for Tariff and
PCVA for adults, children, and neonates. Among adults,
Tariff outperforms PCVA when health care experience
is excluded and is not significantly different than PCVA
when health care experience information is included.
PCVA outperforms Tariff in chance-corrected concor-
dance for the child module both with and without
health care experience information. Tariff achieves
21.6% (without HCE) and 23.9% (with HCE) chance-cor-
r e c t e dc o n c o r d a n c ei nt h en e o n a t em o d u l ea n a l y s i s .
Neonate results between Tariff and PCVA are not
directly comparable because PCVA cannot predict
causes of death for all 11 neonate causes and conse-
quently aggregates the five premature delivery causes
into a single premature delivery cause. Figure 2 provides
details on how well Tariff identifies the true cause as
the second, third, fourth through to sixth cause in the
list. For all age groups, partial chance-corrected concor-
dance increases steadily as extra causes are considered
on the list. It is important to note that partial chance-
corrected concordance includes a correction factor for
concordance due to chance. Tariff achieves 66% partial
chance-corrected concordance if three cause assign-
ments are made for adults, 62% for children, and 52%
for neonates.
Additional file 4 provides cause-specific chance-cor-
rected concordances for Tariff. For adults, when exclud-
ing household recall of health care experience, Tariff
yields median chance-corrected concordances over 50%
for a number of injuries, including bite of venomous
animal, breast cancer, cervical cancer, drowning, esopha-
geal cancer, fires, homicide, maternal, other injuries, and
road traffic. Addition of health care experience raises
chance-corrected concordance over 50% for AIDS,
asthma, and stroke. Additional file 4 also shows that in
children without household recall of health care experi-
ence, median chance-corrected concordance is over 50%
for falls, malaria, and measles. With HCE, the list
expands to also include AIDS, bite of venomous animal,
drowning, fires, road traffic, and violent death. In neo-
nates, the best performance for Tariff is for preterm
delivery and sepsis/birth asphyxia, preterm delivery with
respiratory distress syndrome, congenital malformation,
and stillbirth. Figures 3, 4, and 5 show visual compari-
sons of each cause-specific chance-corrected concor-
dance with and without HCE for adults, children, and
Table 1 Selected tariffs in the adult module of the PHMRC dataset
Signs/Symptoms
Causes Ulcer oozed pus Lump in the neck Convulsions Pain in left arm Free text: “cancer”
Diabetes with skin infection 25 0.5 0.5 1 -0.5
Esophageal cancer -0.5 8.5 -1.5 1 4.5
Hypertensive disorder (maternal) -0.5 0.5 7 -0.5 -0.5
Acute myocardial infarction 0 -1 -0.5 4.5 0.5
Cervical cancer 0 0.5 -0.5 -0.5 7
Tariffs were calculated as explained in the Methods section. These particular tariffs were selected because they demonstrate how the method can be somewhat
intuitive from a medical perspective. For example, an ulcer oozing pus is a plausible sign for a person who died of diabetes with skin infection, though it seems
somewhat less plausible for someone dying of acute myocardial infarction.
Table 2 Median chance-corrected concordance (%) for
Tariff and PCVA with 95% uncertainty interval (UI), by
age group with and without HCE information
Tariff PCVA
Median 95% UI Median 95% UI
Adult No HCE 34.3 (34.1, 34.5) 29.7 (29.4, 29.8)
HCE 44.5 (44.2, 44.7) 44.6 (44.3, 44.8)
Child No HCE 28.8 (28.4, 29.2) 36.3 (35.9, 36.6)
HCE 39.0 (38.4, 39.4) 47.8 (47.1, 48.3)
Neonate No HCE 21.6 (21.2, 22.2) 27.6 (27.2, 28.0)
HCE 23.9 (23.6, 24.4) 33.3 (32.8, 33.7)
Tariff outperforms or matches the performance of PCVA in the adult module,
while PCVA outperforms Tariff in the child module. Results are not
comparable for neonates since PCVA can only make cause assignments on six
neonate causes, while Tariff makes cause assignments on 11 neonate causes.
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value of adding HCE information and demonstrate how
individual cause assignment is difficult for certain causes
when HCE information is not available. For example,
the important adult causes of AIDS, malaria, and TB
have low concordance when HCE information is with-
held, though performance does improve dramatically
when HCE information is added. Similarly, chance-cor-
rected concordance improves roughly four-fold for
AIDS in the child module when HCE is added. Figure 6
shows a comparison for adults with HCE of concor-
dance achieved with Tariff and PCVA applied to the
same 500 test datasets. These results show that PCVA
varies more than Tariff in chance-corrected concor-
dance, despite their median across 500 splits being
approximately the same.
CSMF estimation
To estimate Tariff’s ability to accurately determine
CSMFs, we predicted causes of death for 500 different
test datasets with varying cause compositions. Table 3
shows that Tariff yields more accurate estimates of
CSMFs than PCVA for adults and children, both with
and without health care experience information. Since
PCVA cannot make cause assignments on the full list of
11 neonate causes, it is not possible to directly compare
PCVA and Tariff in accuracy.
Additional file 5 shows the slope, intercept, and root
mean squared error (RMSE) of regressing the estimated
CSMF as a function of true CSMF for all causes across
500 test splits. We have selected four adult causes based
on Additional file 5 to illustrate a range of cases where
Tariff produces good to relatively poor estimates of the
CSMF as a function of the true CSMF. Figure 7 shows
the estimated CSMF for drowning compared to the true
CSMF for drowning in adults across 500 test datasets.
In general, across a wide range of true CSMFs, Tariff
performs well in estimating the CSMF from this cause.
This quality is further evidenced by the results from the
regression. Drowning has an intercept of 1.5%, which
means that even if there are no true deaths from drown-
ing in a VA dataset, Tariff will tend to predict a CSMF
of approximately 1.5%. However, the slope of 0.817 and
the RMSE of 0.006 also indicate that estimations tend to
track the true CSMFs fairly closely, and that estimated
CSMFs will not vary widely for a given true CSMF. For
breast cancer, shown in Figure 8, Tariff can accurately
determine the mortality fractions in test splits with
small to modest numbers of true breast cancer deaths;
Figure 2 Partial chance-corrected concordance for the adult, child, and neonate predictions for making multiple cause of death
assignments for each death. Multiple assignments can be made by looking at the top-ranked causes based on the tariff scores for each cause.
For a given death, for example, AIDS, TB, and pneumonia might be the three most likely causes of death, thus improving the probability that
one of those causes is correct. The partial chance-corrected concordance calculation includes a correction term to compensate for the inherently
higher probability of making a correct assignment when multiple causes are assigned.
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fractions, Tariff tends to underestimate the fraction. The
results from the regression for breast cancer show that
estimates are slightly less noisy than for drowning and
that the method will start to systematically underesti-
mate CSMFs beyond a true CSMF of approximately
2.5%. Figure 9 shows the same relationship for maternal,
with a slightly higher threshold for when the method
begins to underestimate CSMFs. In this case, however,
while there is still a generally good relationship between
the true and estimated CSMFs, at low true CSMFs Tar-
iff tends to overestimate the cause fraction, while at very
high CSMFs, it has a slight tendency to underestimate.
At the other end of the spectrum, Tariff does a poor job
of estimating the population fraction of deaths due to
stomach cancer, shown in Figure 10, and tends to
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Figure 3 Median chance-corrected concordance (%) across 500 test splits, by adult cause with and without HCE.
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Figure 5 Median chance-corrected concordance (%) across 500 test splits, by neonate cause with and without HCE.
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RMSEs provide a measure of the noise or precision in
each cause’s predictions. In the adult predictions includ-
ing the use of HCE information, the RMSE ranged from
0.005 for maternal causes to 0.019 for other noncom-
municable diseases.
We performed similar analyses for the child and neo-
nate results (full regression results also shown in
Additional file 5). Figure 11 demonstrates how Tariff
tends to overpredict measles CSMFs in populations with
a smaller measles fraction. As the true measles fraction
increases, however, Tariff does not systematically over-
or underestimate the mortality fractions to the extent
seen in other causes. Furthermore, the estimates for
measles CSMF in children are much noisier than other
examples for adults. This quality is also evidenced by
the higher RMSE of 0.019. For child sepsis, in contrast,
Tariff tends to underestimate CSMFs as the true cause
fraction increases. The true versus estimated sepsis
CSMFs are shown in Figure 12. The RMSEs for children
are higher than for adults, ranging from 0.013 for road
traffic accidents to 0.033 for malaria.
The neonate CSMF estimation tends to differ from the
true cause fraction more frequently than for child or
adult deaths. Congenital malformation, shown in Figure
13, exemplifies a cause for which Tariff can roughly
determine the correct CSMF regardless of the true
CSMF size. However, other neonatal causes such as pre-
term delivery with respiratory distress syndrome are
subject to much noisier estimates, as shown in Figure
Figure 6 Chance-corrected concordance comparison scatter for 500 splits of PCVA and Tariff adult module estimations. These results
included the use of HCE information.
Table 3 Median CSMF accuracy for Tariff and PCVA with
95% UI, by age group with and without HCE information
Tariff PCVA
Median 95% UI Median 95% UI
Adult No HCE 0.695 (0.690, 0.699) 0.624 (0.619, 0.631)
HCE 0.745 (0.739, 0.753) 0.675 (0.669, 0.680)
Child No HCE 0.642 (0.635, 0.651) 0.632 (0.626, 0.642)
HCE 0.709 (0.704, 0.715) 0.682 (0.671, 0.690)
Neonate No HCE 0.663 (0.655, 0.671) 0.695 (0.682, 0.705)
HCE 0.679 (0.670, 0.689) 0.733 (0.719, 0.743)
PCVA results for neonates are shown at a six-cause level, since analysis was
not possible at the same 11-cause level as Tariff.
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Figure 7 True versus estimated mortality fractions for drowning, adult module with HCE information.
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Figure 8 True versus estimated mortality fractions for breast cancer, adult module with HCE information.
James et al. Population Health Metrics 2011, 9:31
http://www.pophealthmetrics.com/content/9/1/31
Page 10 of 160
5
1
0
1
5
2
0
E
s
t
i
m
a
t
e
d
 
C
a
u
s
e
 
F
r
a
c
t
i
o
n
 
(
%
)
0 5 10 15 20
True Cause Fraction (%)
Figure 9 True versus estimated mortality fractions for maternal causes, adult module with HCE information.
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Figure 10 True versus estimated mortality fractions for stomach cancer, adult module with HCE information.
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Figure 11 True versus estimated mortality fractions for measles, child module with HCE information.
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Figure 12 True versus estimated mortality fractions for sepsis, child module with HCE information.
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Figure 13 True versus estimated mortality fractions for congenital malformation, neonate module with HCE information.
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Figure 14 True versus estimated mortality fractions for preterm delivery with respiratory distress syndrome, neonate module with
HCE information.
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Page 13 of 1614. These results are further reflected in the correspond-
ing coefficients and intercepts seen in Additional file 5,
which allow for assessment of the relationship between
true and estimated CSMFs. As for adults and children,
the RMSE from these regressions indicate which causes
can be estimated with greater precision, even if the esti-
mation is systematically high or low. In the neonate
results including the use of HCE information, the RMSE
ranged from a low of 0.023 for stillbirths to 0.051 for
preterm delivery and birth asphyxia and for preterm
delivery, sepsis, and birth asphyxia.
Discussion
The Tariff Method is a simple additive approach based
on identifying items in a VA interview that are indicative
of particular diseases. It is based on the premise that indi-
vidual items or signs/symptoms should be more promi-
nently associated with certain causes (the “signal”)
compared with others (the “noise”). This simple approach
performs as well as or better than PCVA for adult causes
i na s s i g n i n ga nu n d e r l y i n gc a u s eo fd e a t h ,t h o u g hP C V A
performs better in this comparison for child deaths. At
the level of particular causes, Tariff has higher chance-
corrected concordances than PCVA for 14/34 adult and
8/21 child causes. Results for neonatal deaths are not
comparable due to differences in cause lists. For estimat-
ing CSMFs, Tariff performs better than PCVA for adult
and child deaths in all comparisons with and without
household recall of health care experience. In all compar-
able cases, Tariff yields higher median CSMF accuracy
than PCVA. Overall, at the individual and the CSMF
level, Tariff in general offers a competitive alternative to
PCVA. Performance for assigning neonatal causes of
death, however, is worse than for PCVA.
The tariffs for each cause-item pair have already been
established using Stata code, which will be available
online. Using this pre-existing tariff matrix, the Tariff
Method requires only multiplication and addition to
make cause of death assignments for each individual
death in a given dataset. Though we processed VA
response data to develop our method, users need not
conduct additional processing to use Tariff since our
processing steps can be integrated into the code that
makes cause of death assignments. The absence of a sta-
tistical model or complex computational algorithm
m e a n st h a tt h es t e p si n v o l v e di na s s i g n i n gc a u s eo f
death to a particular death can be completed in a
spreadsheet and are readily available for user scrutiny.
Further, the tariff matrix and algorithm can be imple-
m e n t e do nas i m p l ed e v i c es u c ha sac e l lp h o n e-t h e
Open Data Kit research team at the University of
Washington has already implemented the tariff algo-
rithm on an Android cell phone using their Free/Libre
Open-Source Survey Platform. In other words, tariff-
based cause assignments can be made immediately after
data collection in the field.
One of the key strengths of Tariff is its flexibility.
Each item’s tariff for a cause is computed independently
from all other items. Consequently, any instrument’s
verbal autopsy items that can be mapped to one of the
items in the PHMRC dataset can be evaluated using
Tariff. Other methods, such as Random Forest and Sim-
plified Symptom Pattern, require the testing data to
have the same item set as the data on which the model
was trained. This is an important asset of Tariff because
it allows users to implement the method without having
to recalculate tariffs or revise the algorithm. It can
essentially be used as is for any verbal autopsy instru-
ment with overlapping items with the PHMRC
instrument.
Tariff does not take into account the interdependen-
cies of signs and symptoms conditional on particular
causes. It does not take into account the complex time
sequence captured in open narratives, which are often
used by physicians. How can such a simple algorithm be
more effective than physicians? The answer may lie in
the key attributes of Tariff that distinguish it from other
methods: identification of items that are unusually
important for different causes through computation of
the tariff and the additive rather than multiplicative nat-
ure of the tariff score. The tariffs focus attention on the
specific subset of items that are most strongly related to
a given cause. The additive approach may make Tariff
more robust to measurement error either in the train or
test datasets.
Because of its simplicity, we plan to make available
several different platforms on which to apply Tariff. Pro-
grams in R, Stata, and Python will be available for
assigning a cause for a given death or set of deaths, as
well as a version of Tariff in Excel for users without
training in statistics packages. Tariff will also be avail-
able in the Open Data Kit for use on the Android oper-
ating system for cell phones and tablets. We hope these
tools will lead to widespread testing and application of
Tariff. The full sign/symptom-cause tariff matrix will
also be available for user inspection and application to
other verbal autopsy diagnostic methods such as Ran-
dom Forest and Simplified Symptom Pattern, which rely
on tariffs to identify meaningful signs and symptoms.
The tariffs can also be used to refine further verbal
autopsy instruments, possibly in reducing the number of
survey items, since they show which specific signs/symp-
toms should be included for accurately predicting cer-
tain causes of death. For example, one strategy for item
reduction would be to drop items that have low tariffs
for all causes and then assess the change in CSMF accu-
racy or chance-corrected concordance when cause
assignment is undertaken with the restricted item set.
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would seem that Tariff provides an attractive alternative.
Compared to the current version of InterVA [16], Tariff
performs markedly better. We believe that users inter-
ested in rapid, low-cost, easy-to-understand VA methods
should consider Tariff. As indicated by analysis of CSMF
accuracy and true versus estimated CSMF regressions,
there are certain cases where Tariff may overestimate or
underestimate CSMFs for particular causes. It will be
important for users of Tariff to understand these limita-
tions, particularly for the purposes of using Tariff to bet-
ter inform public health decision-making. Future
research may yield new techniques to more accurately
determine CSMFs based on verbal autopsy through back
calculation. Tariff is also attr a c t i v et ot h o s ew h ow i s ht o
examine the exact computation by which a verbal
autopsy algorithm makes a cause of death assignment. In
the future, as more gold standard deaths are collected to
augment existing causes in the PHMRC dataset, or for
new causes, it will be straightforward to revise existing
tariffs or report tariffs for new causes. This step is parti-
cularly easy compared to other computer-automated
methods, for which expansion with more causes requires
revision of the algorithm itself.
Conclusion
Verbal autopsies are likely to become an increasingly
important data collection platform in areas of the world
with minimal health information infrastructure. To date,
methods for evaluating verbal autopsies have either been
expensive or time-consuming, as is the case with PCVA,
or they have been computationally complex and difficult
for users to implement in different settings. This has
inhibited the widespread implementation of verbal
autopsy as a tool for policymakers and health research-
ers. Tariff overcomes both of these challenges. The
method is transparent, intuitive, and flexible, and,
importantly, has undergone rigorous testing to ensure
its validity in various settings through the use of the
PHMRC verbal autopsy dataset. Using the method on
verbal autopsies to determine both individual-level cause
assignment and cause-specific mortality fractions will
greatly increase the availability and utility of cause of
death information for populations in which comprehen-
sive and reliable medical certification of deaths is unli-
kely to be achieved for many years to come, but is
urgently needed for health policies, programs, and mon-
itoring progress with development goals.
Additional material
Additional file 1: Top 40 signs/symptoms based on absolute value
tariffs for each cause in the adult module. These tariffs were
calculated using the formula provided in the Methods section.
Additional file 2: Top 40 signs/symptoms based on absolute value
tariffs for each cause in the child module. These tariffs were
calculated using the formula provided in the Methods section.
Additional file 3: Top 40 signs/symptoms based on absolute value
tariffs for each cause in the neonate module. These tariffs were
calculated using the formula provided in the Methods section.
Additional file 4: Median chance-corrected concordance (%) across
500 Dirichlet splits, by age group and cause with and without HCE.
Additional file 5: Slope, intercept, and RMSE from linear regression
of estimated versus true CSMFs, by age group and cause with and
without HCE.
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CSMF: cause-specific mortality fraction; HCE: health care experience; PCVA:
physician-certified verbal autopsy; RMSE: root mean squared error; VA: verbal
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